The National Institutes of Health (NIH) intends to award a non-competitive contract to Illumina, Inc. for a NextSeq2000 sequencer to support the NHGRI Microarrays and Single-cell Genomics Core. The procurement is conducted under simplified acquisition procedures and is not expected to exceed the simplified acquisition threshold of $350,000. The core provides full-service genomics and transcriptomics technologies for intramural investigators, processing RNA/DNA samples with standardized protocols. Performance of services will be at the NIH facility in Bethesda, Maryland. Interested parties must submit responses by June 29, 2026, demonstrating their capability to fulfill the requirement.